The Irish Times

Former Eircom finance director Peter Lynch dies aged 63

The one-time stockbroker from Belfast was considered dynamic and gregarious

Tue Aug 31 2021 - 16:12

Irish biotech Amarin gears up for drug launch in Europe

Company’s cardiovascular drug should be cleared in next six weeks for EU use

Wed Feb 24 2021 - 07:33

Irish heart drug group Amarin slumps 70% over patent suit loss

Nevada court rules patents are invalid in crunch battle with generic rivals

Tue Mar 31 2020 - 10:16

Irish pharma group says sales of heart drug will top projections

Amarin doubling size of US sales force as FDA sanctions expanded market for Vascepa

Tue Jan 07 2020 - 16:12

Amarin secures approval for heart drug Vascepa in Canada

Irish pharma group gearing up for legal battle over patents with generic drugmakers

Thu Jan 02 2020 - 19:25

Winners and losers in a year of extremes in the business world

Green Reit and CRH among winners as Boeing, Denis O’Brien and RTÉ join losers

Fri Dec 27 2019 - 05:12

Amarin secures European review for cardio drug Vascepa

Purified fish oil drug has been recommended by FDA for wider market approval

Mon Dec 02 2019 - 18:48

Amarin president named US EY Entrepreneur of the Year for life sciences

John Thero, CEO of fish-oil drug specialist, accepts award for Irish-domiciled company

Tue Nov 19 2019 - 18:40

No home run yet for Amarin’s heart drug Vascepa

Cantillon: Unanimous FDA panel backing hides differences in view over potential

Sat Nov 16 2019 - 05:59

Amarin shares jump as FDA panel backs heart drug

US regulator’s advisory committee backs dramatic increase in market for purified fish oil drug Vascepa

Fri Nov 15 2019 - 17:52

Roll up, roll up: capitalism will drive cannabis legalisation in Ireland

Legalisation is coming, no matter what Irish policymakers may say now

Fri Aug 23 2019 - 05:05

Tariff threats to EU goods do little to curb gains in European share

BoI and Aryzta drag Iseq lower but Ryanair goes higher

Tue Jul 02 2019 - 18:37

Shares jump 15% in Ireland’s Amarin on hopes for heart drug

Strong increase in proft forecast on the back of sales of fish oil drug in the US

Tue Jul 02 2019 - 13:29

Amarin president named EY Entrepreneur of the Year

John Thero of the fish oil drug specialist recognised for company’s drug, Vascepa

Sun Jun 23 2019 - 17:09

Amarin jumps on FDA priority review for heart drug

Irish company’s Vascepa on track for earlier than expected approval

Wed May 29 2019 - 16:24

Irish VC group Fountain Healthcare Partners raises €118m

Group beats €100m target and intends to invest the bulk of the fund in Europe and US

Thu May 23 2019 - 20:21

Amarin’s heartwarming bulletin for firm’s shareholders

Stock advances over fivefold in 12 months on evidence of medicine’s cardiovascular effect

Tue May 21 2019 - 05:13

Amarin to seek European approval for heart drug Vascepa

Clinical trials show Irish company’s fish-oil drug cut incidence of heart attacks and strokes

Mon May 20 2019 - 19:54

Dalata named company of the year at ‘Irish Times’ business awards

The Republic’s largest hotel group has more than 9,000 rooms across its portfolio

Wed May 08 2019 - 19:51

The Irish Times Company of the Year: the four finalists

Stripe, Dalata, Glanbia and Amarin shortlisted on back of standout years

Mon Mar 25 2019 - 04:20

Business 2018: the winners and the losers

The last 12 months proved to be another year of mixed fortunes in corporate Ireland

Tue Dec 25 2018 - 15:45

Irish firm Amarin confirms heart drug success

Some concern over neutrality of placebo and whether it might have boosted Vascepa data

Sun Nov 11 2018 - 15:50

Tetrarch buys 470 acres of Howth, bankers’ bonuses and Ryanair’s turbulent week

‘Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

Fri Oct 05 2018 - 06:30

Amarin – an overnight success 10 years in the making

After several false starts, way is clear for John Thero to take Vascepa cholesterol drug to market

Fri Oct 05 2018 - 05:50

Amarin surges as trial results exceed expectations

Company’s Vascepa drug proves effective in reducing risk from stroke and heart attack

Mon Sept 24 2018 - 12:44

Taoiseach defends relationship with chair of firm that HSE chief has joined

Varadkar backs Minister’s consent granted to O’Brien to take up board role at US firm

Thu May 03 2018 - 01:00

Amarin reports 59% jump in sales for Vascepa drug

Irish biotech’s drug used to treat US patients with high levels of blood fats

Tue Feb 28 2017 - 19:32

52 Places to Go in 2017

There are thousands of getaways waiting to be explored. Here are some ideas to get you started

Wed Jan 11 2017 - 12:30

Amarin reports strong sales growth for Vascepa

Company targets expanded market share for fish oil drug that cuts risk of heart disease

Thu Aug 04 2016 - 19:28

Amarin reports 62% rise in fourth quarter sales of Vascepa

Costs, including ongoing R&D, means the company reports loss of $21.9 million for the quarter and $115.2 million for full year

Thu Feb 25 2016 - 20:00

Drug minnow Amarin downs FDA in constitutional battle

Irish pharma firm wins major victory over FDA on off-label promotion of its drug Vascepa

Fri Aug 14 2015 - 07:15

Irish drug company Amarin defeats FDA in US lawsuit

US court rules regulator cannot bar company promoting off label use for drug

Fri Aug 07 2015 - 17:13

Cantillon: Amarin faces down the mighty FDA

Small Irish pharma group sues US regulator over restricting its right to free speech

Thu Jul 02 2015 - 01:00

Pharma group Amarin sues FDA over right to brief doctors on drug

Dublin group says regulator refusal to allow it discuss off label use breaches US first amendment rights and puts it at a disadvantage to rival unregulated products

Fri May 08 2015 - 19:18